help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2006-2580
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vejbjerg, P.
Right arrow Articles by Jørgensen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vejbjerg, P.
Right arrow Articles by Jørgensen, T.
Related Collections
Right arrow Thyroid
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 4 1397-1401
Copyright © 2007 by The Endocrine Society

Effect of a Mandatory Iodization Program on Thyroid Gland Volume Based on Individuals’ Age, Gender, and Preceding Severity of Dietary Iodine Deficiency: A Prospective, Population-Based Study

Pernille Vejbjerg, Nils Knudsen, Hans Perrild, Allan Carlé, Peter Laurberg, Inge Bülow Pedersen, Lone B. Rasmussen, Lars Ovesen and Torben Jørgensen

Department of Internal Medicine I (P.V., N.K., H.P.), Bispebjerg Hospital, University of Copenhagen, 2400 Copenhagen, Denmark; Department of Endocrinology (A.C., P.L., I.B.P.), Aalborg Hospital, University of Aarhus, 9000 Aalborg, Denmark; Department of Nutrition (L.B.R.), Danish Institute for Food and Veterinary Research, 2860 Søborg, Denmark; Danish Heart Association (L.O.), 1127 Copenhagen, Denmark; and Research Centre for Prevention and Health (P.V., N.K., T.J.), 2600 Glostrup, Denmark

Address all correspondence and requests for reprints to: Pernille Vejbjerg, Department of Internal Medicine, Bispebjerg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen NV, Denmark. E-mail: pervej01{at}glostruphosp.kbhamt.dk.


    Abstract
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Objective: We aimed to evaluate prospectively the effect of 4 yr of mandatory iodization of salt (13 ppm iodine) on thyroid volume in two regional areas with respectively mild and moderate iodine deficiency.

Methods: Two separate cross-sectional studies were performed before (n = 4649) and after (n = 3570) the iodization in year 2000 in two areas with mild and moderate iodine deficiency. Women aged 18–22, 25–30, 40–45, and 60–65 yr and men aged 60–65 yr were examined. Thyroid ultrasonography was performed.

Results: A lower median thyroid volume was seen in all age groups after iodization. The largest relative decline was found among the younger females from the area with previous, moderate iodine deficiency. Only a minor decrease was seen among the youngest participants in the area with previous, mild iodine deficiency. After iodization, there were no regional differences in median thyroid volume in the age groups younger than 45 yr. When adjusted for confounders, a lower mean volume was seen among those with multiple nodules in both areas and in the group with diffuse structure in the area with moderate iodine deficiency. Before the iodization, 17.6% of the total cross-section had thyroid enlargement; after the iodization, 10.9% of the cross-section had thyroid enlargement.

Conclusion: In this prospective study, we demonstrated a lower thyroid volume in all age groups after iodization of salt. The decline was largest in the area with former, moderate iodine deficiency. The equal volumes in the regions among the younger age groups indicate approximation to an optimal iodine intake.


    Introduction
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
WORLDWIDE, IODIZATION PROGRAMS have been initiated to prevent iodine deficiency disorders. Iodization of salt is considered the appropriate method for iodine fortification in prosperous countries (1); however, careful monitoring is essential because excessive iodine intake can also be disadvantageous and even small differences in iodine intake have proven to be decisive for the prevalence of endemic goiter and other iodine-related thyroid diseases (2, 3, 4, 5, 6).

One study has followed the initiation of a population-based iodine program in an area with severe iodine deficiency (7) showing a significant reduction in median thyroid volume in children 2 yr after the introduction of iodized salt, whereas a 1-yr study focusing on thyroid autoimmunity did not find a significant reduction in thyroid volume (8). Most previous studies, however, evaluated distribution of disease patterns before or after a modification of iodization level (9, 10).

In Denmark, iodization of salt was prohibited from 1982 until 1998, when an optional iodization of salt was initialized. This led to only a limited use of iodized salt, so from year 2000 iodization of all household salt and salt used in the bread industry was made mandatory to a level of 13 ppm iodine. Calculations based on the Danish national dietary survey showed that this fortification should increase median iodine intake to 150 µg/d. The design of our study with two cross-sectional studies, one before and one 4 yr after the iodization of salt, in two areas in Denmark with respectively mild and moderate iodine deficiency (11), enables us to prospectively investigate the consequences of iodization on a population level.


    Subjects and Methods
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Cross-sectional study before iodization of salt

The first study (1997–1998) was carried out before the iodization of salt in two regions suspected to be respectively mildly (the northern part of Copenhagen, eastern Denmark) and moderately (Aalborg, western Denmark) iodine deficient (12, 13). All procedures (e.g. invitation procedure, questionnaires, and examination) were similar to the procedures used in the current study carried out after the iodization of salt. For the preiodization study, 9274 persons were invited and 4649 (50.1%) participated. The study is described in detail elsewhere (4).

Cross-sectional study after iodization of salt

For the current cross-sectional study, subjects were invited from the same two regions in Denmark, now known to have been mildly iodine deficient and moderately iodine deficient before iodization, with median urinary iodine of respectively 61 and 45 µg/liter in the first study excluding subjects taking vitamin tablets containing iodine (4). The crude median values in the two regions were 68 and 53 µg/liter, respectively. From these areas, all women born in Denmark aged 18–22, 25–30, 40–45, and 60–65 yr and men born in Denmark aged 60–65 yr who did not participate in the previous study were drawn from the civil registration system (n = 37,963), a register where all persons living in Denmark are registered by an exclusive 10-digit number. The groups were largely chosen to represent women before childbearing age, in the childbearing age, and after the childbearing age (pre- and postmenopausal). To reflect the female population, pregnant women were included. For comparison between the genders, a group of men was included corresponding to the group of postmenopausal women. The persons were given random numbers within each sex and age group and were subsequently invited in order of the random numbers. The goal was to reach 350 participants in each sex and age group in each region, and the number of invitations was regulated throughout the study to attain this. The participation rate was 46.6%, highest in the area with previous moderate iodine deficiency (Table 1Go).


View this table:
[in this window]
[in a new window]

 
TABLE 1. Participation rates in the two regions of Denmark in 2004–2005 after iodization of salt

 
The study was carried out from 28 April 2004 to 14 July 2005. A total of 8103 subjects were invited. Of these, 445 were impossible to reach because of change in address or death. The subjects were invited by letter and if there was no response, an additional letter was sent. If the subject refused to participate or did not answer at all, a short questionnaire was sent. To evaluate potential selection bias, information on thyroid disease was sought in the National Patient Register, where information (diagnoses and operations) on all discharges from somatic hospitals in Denmark has been registered since 1977 and all outpatient contacts since 1995. Participants who reported previous treatment with medicine, surgery, or radioactive iodine therapy for thyroid disease (goiter, nodules, hyper- or hypothyroidism, cancer) were excluded from the current analyses.

The study was carried out by two teams, each comprising a physician and a sonographer, and in Aalborg additionally a laboratory technician.

The participant answered questionnaires regarding previous thyroid disease, lifestyle (i.e. smoking, eating, and drinking habits), socioeconomic factors, and medication. In case of doubt, the questionnaires were amplified in a subsequent interview.

An ultrasonography was performed using a Sonoline Versa Pro 7.5 MHz 70 mm linear transducer (Siemens, Munich, Germany), effective length 62 mm. Thyroid volume was calculated as maximal length*width*depth*{pi}/6 of each lobe. Thyroid enlargement was defined as a thyroid volume greater than 18 ml for women and 25 ml for men, which corresponds to the mean + 3 SD values in iodine-sufficient populations (14). Records were made on distinct nodules larger than 5 mm. In the event of more than three nodules in a lobe, only the three largest were registered. The structure of the gland was classified as diffuse (no registered nodules), solitary nodule (one thyroid nodule), or multinodular (more than one thyroid nodule). The two sonographers previously performed the ultrasonographies in the corresponding study carried out before the iodization of salt using the same apparatus. Their comparability was studied and described (15). Before the current study, a confirmatory interobservational study was performed showing continued good correlation (r = 0.95) between the observers in determination of thyroid size. In judging the left lobe, there was a tendency toward larger volume judged by the observer from the area with mild iodine deficiency. This tendency reached significance in the latest interobservational study, but has been of similar size throughout the whole study period.

Nonfasting spot urinary samples were collected during the time interval from 0800–1800 h and analyzed for iodine concentration for 3554 subjects. The urine samples were digested by alkaline ashing and analyzed by the Ce4+/As3+ method for iodine contents as previously described (16, 17). The median iodine excretion in the combined cross-section was 101 µg/liter. It was 108 µg/liter in Copenhagen and 93 µg/liter in Aalborg, making the areas iodine sufficient and mildly iodine deficient according to criteria outlined by the World Health Organization (18). After exclusion of subjects taking individual iodine supplementation, the figures were 99 and 86 µg/liter, respectively. This corresponds to an increase in median values of 38 and 41 µg/liter compared with values before iodization of salt. The study was approved by the regional Ethics Committee, and all participants gave written informed consent.

Statistics

Data processing was conducted using SAS 9.1 statistical software (SAS Institute Inc., Cary, NC). The desired number of participants was established by a power calculation to be able to demonstrate a potential decrease in thyroid size of 1 ml in the young adults after the iodization of salt ({alpha} = 0.05, ß = 0.20). Nonparametric tests (Mann-Whitney U/Wilcoxon test) were used to compare thyroid volume before and after iodization of salt and in between the regions, because the distribution of volumes was skewed toward higher values. Comparisons between frequencies were done using {chi}2 test or Fisher’s test. In regression models, possible confounding by region, sex, age, lifestyle (tobacco, alcohol, iodine supplementation, and oral contraceptives), familial disposition (at least one first-degree relative with thyroid disease), educational level, parity, and body surface area [0.0235 x height (cm)0.42246 x weight (kg)0.51456] (19) were considered. A reparameterization of cohort and region of inhabitancy was done because of interaction between the two. Because of skewness, thyroid volume was logarithmically transformed for analyses in regression models.


    Results
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Thyroid volume

Median thyroid volume was lower in all age groups after iodine fortification compared with before (Table 2Go). The largest absolute difference, 2.6 ml, was found among the elderly men in the area with previous, moderate iodine deficiency, and the largest relative difference was found among the younger females from the area with previous, moderate iodine deficiency. Only a minor decrease, 0.4 ml, was seen among the youngest participants in the area with previous, mild iodine deficiency (P = 0.051). After the iodization, there were no regional differences in median thyroid volume in the age groups younger than 45 yr old. The distribution of thyroid volumes shifted toward lower values, and the range narrowed in both regions (Table 2Go).


View this table:
[in this window]
[in a new window]

 
TABLE 2. Median thyroid volume in two areas, with former mild and former moderate iodine deficiency (ID) before and after mandatory iodization of salt in Denmark and relative decline

 
In linear regression models, the mean volume was 12% [95% confidence interval (CI), 9–15%] lower after than before the iodization of salt in the area with moderate iodine deficiency and 6% (95% CI, 2–9%) lower in the area with mild iodine deficiency for fixed values of age, sex, region, lifestyle (tobacco, alcohol, iodine supplementation, and oral contraceptives), education, parity, and body surface area. A decline in median thyroid size was seen independently of thyroid structure (Fig. 1Go). However, when adjusted for confounders, a significantly lower mean volume was only seen in the group of participants with multiple nodules in both regions and in the group with diffuse structure in the region with moderate iodine deficiency (Table 3Go).


Figure 1
View larger version (38K):
[in this window]
[in a new window]

 
FIG. 1. Crude median thyroid volume before and after iodization of salt according to thyroid structure [solitary nodule, diffuse (no nodules > 5 mm), or multinodular] in two regions of Denmark with respectively mild and moderate iodine deficiency before iodization. Subjects treated for thyroid disease (n = 420) were excluded.

 

View this table:
[in this window]
[in a new window]

 
TABLE 3. Thyroid structure and proportional relationship between thyroid volumes before and after iodization of salt

 
A decline in overall prevalence of thyroid enlargement from 17.6 to 10.9% was found after the iodization of salt (P < 0.001), and there was no longer a significant difference in prevalence between the two regions among the youngest participants (Table 4Go). The prevalence of large goiter, greater than 50 ml, also declined from 1.68 to 0.89% (P < 0.01).


View this table:
[in this window]
[in a new window]

 
TABLE 4. Prevalence of thyroid enlargement in two areas with former mild and former moderate iodine deficiency (ID), before and after mandatory iodization of salt in Denmark

 
Nodules

No difference was found, either in simple or in logistic regression models, in overall prevalence of solitary thyroid nodules larger than 10 mm (5.9 vs. 5.6%; P = 0.573) or multiple nodules (11.3 vs. 10.3%; P = 0.173) in the two cross-sections. The overall median size of registered solitary nodules was 9.0 mm before the iodization and 10.1 mm after the iodization (P = 0.04), and the median size of the largest of multiple nodules in an individual was 13.0 mm before iodization and 12.8 mm after iodization (P = 0.48). As expected, there was an increase in prevalence of nodules with increasing age. This was unchanged from before the iodization (4).

Data validation

In the present cross-sectional study there were no significant differences between participant and nonparticipant regarding prior thyroid dysfunction or thyroid surgery based on data from the National Patient Register, but the participants in Aalborg were more likely to have a known goiter diagnosis than the nonparticipants in Aalborg [odds ratio, 3.1 (95% CI, 1.6–6.0)]. This was not the case in Copenhagen [odds ratio, 1.2 (95% CI, 0.7–2.0)]. There were no differences between participants and responders to the short questionnaire in self-reported thyroid disease in any of the regions.


    Discussion
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
In this prospective study of an adult population, we showed a lower median thyroid volume independent of sex and age and a decrease in prevalence of thyroid enlargement after 4 yr of mandatory iodization of salt in Denmark. We have no knowledge of similar prospective studies of adult populations related to the introduction of iodized salt. One other study used a prospective design studying children: Zimmermann et al. (7) examined school children in an area with severe iodine deficiency and found declining median thyroid volume, especially in the youngest children, during a 4-yr period of iodization of salt. Studies following changes in connection with altered regimes of iodization have shown varying results from no change in occurrence of palpable goiter among children 1 yr after a shift from optional to mandatory iodization (20) to normalization of goiter prevalence measured by ultrasonography among children 18 months after iodization in a small randomized study of different iodization regimes (21).

We found an effect in all investigated age groups with reduction in median thyroid volume after 4 yr of iodization, with normalization of thyroid volume in the younger age groups, but continued high rates of thyroid enlargement in subjects over 40 yr. This shows an effect of iodization of salt across life span but indicates that after long-standing exposure to iodine deficiency it may take years or even generations to normalize thyroid volumes in the population. The effect of iodization was most prominent and remained after adjustment for other risk factors among participants who had multinodular thyroid disease and among participants with diffuse structure from the area with the most pronounced previous iodine deficiency. Thus, the effect was primarily seen in subjects with clear signs of iodine deficiency. Additionally, we found a decrease in prevalence of large goiter (>50 ml). It could have been expected that the enlargement seen in multinodular glands was irreversible to a large extend, but this did not seem to be the case. A fall in the prevalence of large thyroids and multinodular thyroids could be explained by reduction in volume of already existing enlargements and/or by lower occurrence of new cases. However, the relative short period of time from mandatory iodization to the second investigation may suggest that the first option is most important, because the development of a multinodular goiter demands a relatively long time interval. The lower volume found after iodization is probably mainly caused by shrinkage of the perinodular tissue, because the prevalence of nodules was unchanged as was the median size of the nodules. There was a difference in effect of iodization of salt in the two regions: the largest volume reduction was seen in the area with moderate iodine deficiency, and only an insignificantly lower volume was seen among the youngest adults in the area with mild iodine deficiency, individuals who were teenagers when the iodization program was initiated.

These findings indicate approximation to an optimal iodine intake in Denmark judged by thyroid volumes, which are now resembling thyroid volumes in areas considered iodine replete, e.g. Amsterdam, The Netherlands (mean thyroid volume, 10.7 ml among 20 to 70 yr olds) (22) and Sweden (median thyroid volume, 11.5 ml among adolescents, 14.3 ml among 60 to 65 yr olds) (23). An important question is whether such an increase in iodine intake is associated with an increase in the occurrence of other thyroid disorders than goiter. Data from the DanThyr-register shows a significant increase in the incidence of hyperthyroidism, not only as expected among the older individuals with multinodular goiter but also among the young individuals (24). Therefore, continued surveillance of the iodine program is essential.

The rate of attendance was only 46.6%, which introduces a possible selection bias. We have, however, self-reported information regarding previous thyroid disease on further 26.9% and data from the National Patient Register regarding previous thyroid diagnosis and/or operations on all invited subjects. These data show an overrepresentation of previous goiter diagnosis among the participants in Jutland compared with nonparticipants, possibly causing an overestimation of goiter prevalence in this region. No differences in prevalence of self-reported thyroid disease were found between participants and responders to the short questionnaire in either region. Prior thyroid goiter diagnosis (in registers and self-reported) was generally more common among participants than among nonparticipants in the first cross-section (4). This indicates that participants in the second cross-section are "healthier" than participants in the previous cross-section. This could cause an overestimation of the difference in thyroid volume and thyroid enlargement between the two cross-sections. However, participants known to have been treated for thyroid disease were excluded from the analyses, and only a few diagnosed with thyroid enlargement during the study were aware of this beforehand, making selection bias less likely. The difference between the regions in previous goiter diagnosis based on data from the National Patient Register in the second cross-section could cause an overestimation of median thyroid volume in the area with previous moderate iodine deficiency, and the actual difference in volume between the regions after the iodization might be even smaller than reported.

The strength of the study is the planned prospective design with investigation of similar age-stratified populations before and after the iodization of salt with standardized procedures between the regions and between the two compared cross-sectional studies. The two ultrasonographers performed the ultrasonographies in both studies, and their interobservational relationship was investigated before the first study (15) and was continuously checked during the study periods. All procedures in the second study were uniform with those in the first study, enabling us to make direct comparisons of thyroid volumes and prevalence of thyroid enlargement before and after the iodization.

Conclusively, with a prospective design and standardized procedures, we demonstrated approximation to an optimal iodine intake in Denmark, with normalization of thyroid size among the young individuals and reduction in prevalence of thyroid enlargement, 4 yr after mandatory iodization of salt. Continued monitoring of the iodization program is crucial in defining the appropriate level of iodization.


    Acknowledgments
 
We express our thanks to Ingelise Leegaard and René Fiege, who carefully performed the ultrasonographies.


    Footnotes
 
This work was supported by Musikforlæggerne Agnes og Knut Mørks Foundation, H:S’s Research Foundation, Tømmerhandler Vilhelm Bang Foundation, and North Jutland County Research Foundation.

Disclosure Statement: P.V., N.K., H.P., A.C., P.L., I.B.P., L.O., and T.J. have nothing to declare. L.B.R received lecture fees from the Danish Meat Association and Arla Foods.

First Published Online January 30, 2007

Abbreviation: CI, Confidence interval.

Received November 28, 2006.

Accepted January 22, 2007.


    References
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 

  1. Clar C, Wu T, Liu G, Li P 2002 Iodized salt for iodine deficiency disorders. A systematic review. Endocrinol Metab Clin North Am 31:681–698[CrossRef][Medline]
  2. Bulow Pederson I, Laurberg P, Knudsen N, Jorgensen T, Perrild H, Ovesen L, Rasmussen LB 2005 A population study of the association between thyroid autoantibodies in serum and abnormalities in thyroid function and structure. Clin Endocrinol (Oxf) 62:713–720[CrossRef][Medline]
  3. Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L, Perrild H 2000 Comparative study of thyroid function and types of thyroid dysfunction in two areas in Denmark with slightly different iodine status. Eur J Endocrinol 143:485–491[Abstract]
  4. Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L, Perrild H 2000 Goitre prevalence and thyroid abnormalities at ultrasonography: a comparative epidemiological study in two regions with slightly different iodine status. Clin Endocrinol (Oxf) 53:479–485[CrossRef][Medline]
  5. Stanbury JB, Ermans AE, Bourdoux P, Todd C, Oken E, Tonglet R, Vidor G, Braverman LE, Medeiros-Neto G 1998 Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 8:83–100[Medline]
  6. Carle A, Laurberg P, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB, Jorgensen T 2006 Epidemiology of subtypes of hypothyroidism in Denmark. Eur J Endocrinol 154:21–28[Abstract/Free Full Text]
  7. Zimmermann MB, Hess SY, Adou P, Toresanni T, Wegmuller R, Hurrell RF 2003 Thyroid size and goiter prevalence after introduction of iodized salt: a 5-y prospective study in schoolchildren in Cote d’Ivoire. Am J Clin Nutr 77:663–667[Abstract/Free Full Text]
  8. Zimmermann MB, Moretti D, Chaouki N, Torresani T 2003 Introduction of iodized salt to severely iodine-deficient children does not provoke thyroid autoimmunity: a one-year prospective trial in northern Morocco. Thyroid 13:199–203[CrossRef][Medline]
  9. Delange F, De Benoist B, Pretell E, Dunn JT 2001 Iodine deficiency in the world: where do we stand at the turn of the century? Thyroid 11:437–447[CrossRef][Medline]
  10. WHO 2004 Iodine status worldwide. Geneva: WHO
  11. Rasmussen LB, Ovesen L, Bulow I, Jorgensen T, Knudsen N, Laurberg P, Perrild H 2002 Dietary iodine intake and urinary iodine excretion in a Danish population: effect of geography, supplements and food choice. Br J Nutr 87:61–69[CrossRef][Medline]
  12. Knudsen N, Jorgensen T, Rasmussen S, Christiansen E, Perrild H 1999 The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin Endocrinol (Oxf) 51:361–367[CrossRef][Medline]
  13. Pedersen KM, Nohr SB, Laurberg P 1997 [Iodine intake in Denmark]. Ugeskr Laeger 159:2201–2206[Medline]
  14. Gutekunst R, Becker W, Hehrmann R, Olbricht T, Pfannenstiel P 1988 [Ultrasonic diagnosis of the thyroid gland]. Dtsch Med Wochenschr 113:1109–1112[Medline]
  15. Knudsen N, Bols B, Bulow I, Jorgensen T, Perrild H, Ovesen L, Laurberg P 1999 Validation of ultrasonography of the thyroid gland for epidemiological purposes. Thyroid 9:1069–1074[Medline]
  16. Laurberg P 1987 Thyroxine and 3,5,3'-triiodothyronine content of thyroglobulin in thyroid needle aspirates in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 64:969–974[Abstract/Free Full Text]
  17. Wilson B, Van Zyl A 1967 The estimation of iodine in thyroidal amino acids by alkaline ashing. S Afr J Med Sci 32:70–82[Medline]
  18. WHO, UNICEF, ICCIDD 2001 Assessment of iodine deficiency disorders and monitoring their elimination. Geneva: WHO
  19. Gehan EA, George SL 1970 Estimation of human body surface area from height and weight. Cancer Chemother Rep 54:225–235[Medline]
  20. Jooste PL, Weight MJ, Lombard CJ 2000 Short-term effectiveness of mandatory iodization of table salt, at an elevated iodine concentration, on the iodine and goiter status of schoolchildren with endemic goiter. Am J Clin Nutr 71:75–80[Abstract/Free Full Text]
  21. Zhao J, Xu F, Zhang Q, Shang L, Xu A, Gao Y, Chen Z, Sullivan KM, Maberly GF 1999 Randomized clinical trial comparing different iodine interventions in school children. Public Health Nutr 2:173–178[Medline]
  22. Berghout A, Wiersinga WM, Smits NJ, Touber JL 1987 Determinants of thyroid volume as measured by ultrasonography in healthy adults in a non-iodine deficient area. Clin Endocrinol (Oxf) 26:273–280[Medline]
  23. Milakovic M, Berg G, Nystrom E, Lindstedt G, Gebre-Medhin M, Eggertsen R 2004 Urinary iodine and thyroid volume in a Swedish population. J Intern Med 255:610–614[CrossRef][Medline]
  24. Pedersen IB, Laurberg P, Knudsen N, Jorgensen T, Perrild H, Ovesen L, Rasmussen LB 2006 Increase in incidence of hyperthyroidism predominantly occurs in young people after iodine fortification of salt in Denmark. J Clin Endocrinol Metab 91:3830–3834[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
H. Volzke, N. Friedrich, S. Schipf, R. Haring, J. Ludemann, M. Nauck, M. Dorr, G. Brabant, and H. Wallaschofski
Association between Serum Insulin-Like Growth Factor-I Levels and Thyroid Disorders in a Population-Based Study
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4039 - 4045.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. J. Bonnema, V. E. Nielsen, H. Boel-Jorgensen, P. Grupe, P. B. Andersen, L. Bastholt, and L. Hegedus
Improvement of Goiter Volume Reduction after 0.3 mg Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy in Patients with a Very Large Goiter: A Double-Blinded, Randomized Trial
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3424 - 3428.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Bulow Pedersen, P. Laurberg, N. Knudsen, T. Jorgensen, H. Perrild, L. Ovesen, and L. B. Rasmussen
An Increased Incidence of Overt Hypothyroidism after Iodine Fortification of Salt in Denmark: A Prospective Population Study
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3122 - 3127.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vejbjerg, P.
Right arrow Articles by Jørgensen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vejbjerg, P.
Right arrow Articles by Jørgensen, T.
Related Collections
Right arrow Thyroid


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals